Matsushita K, Sato C, Bruckert C, Gong D, Amissi S, Hmadeh S, Fakih W, Remila L, Lessinger JM, Auger C, Jesel L, Ohlmann P, Kauffenstein G, Schini-Kerth VB, Morel O

Atherosclerosis. 2024 05 23;:117595

COVID-19 promotes endothelial dysfunction and thrombogenicity: Role of pro-inflammatory cytokines/SGLT2 pro-oxidant pathway.

Mroueh A, Fakih W, Carmona A, Trimaille A, Matsushita K, Marchandot B, Qureshi AW, Gong DS, Auger C, Sattler L, Reydel A, Hess S, Oulehri W, Vollmer O, Lessinger JM, Meyer N, Pieper MP, Jesel L, Bäck M, Schini-Kerth V, Morel O

J Thromb Haemost. 2023 10 3;:

COVID-19 exposure in SARS-CoV-2-seropositive hospital staff members during the first pandemic wave at Strasbourg University Hospital, France.

Velay A, Gallais F, Wendling MJ, Bayer S, Reix N, Schneider A, Glady L, Collongues N, Lessinger JM, Hansmann Y, Kling-Pillitteri L, De Sèze J, Gonzalez M, Schmidt-Mutter C, Meyer N, Fafi-Kremer S

Infect Dis Now. 2021 Nov 11;:

High SARS-CoV-2 seroconversion rate among geriatric staff from Strasbourg University Hospitals.

Panaget B, Velay A, Gontard L, Severac F, Meyer M, Antoni E, Kaltenbach G, Kling-Pillitteri L, Sammour Y, Hansmann Y, Hernandez C, Lavigne T, Lessinger JM, Gonzalez M, Wendling MJ, Gallais F, Kepka SG, Fafi-Kremer S

Infect Control Hosp Epidemiol. 2021 Sep 6;:1-12

Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection.

Gallais F, Gantner P, Bruel T, Velay A, Planas D, Wendling MJ, Bayer S, Solis M, Laugel E, Reix N, Schneider A, Glady L, Panaget B, Collongues N, Partisani M, Lessinger JM, Fontanet A, Rey D, Hansmann Y, Kling-Pillitteri L, Schwartz O, De Sèze J, Meyer N, Gonzalez M, Schmidt-Mutter C, Fafi-Kremer S

EBioMedicine. 2021 Aug 26;71:103561

[Myocardial injury in coronavirus disease 19 (Covid-19): main pathophysiological mechanisms and clinical utility of cardiac biomarkers].

Kamel S, Raynor A, Zozor S, Lacape G, Brunel V, Nivet-Antoine V, Collin-Chavagnac D, Peoc'h K, Cohen A, Lassoued AB, Chévrier M, Alemann M, Lessinger JM, Bérard AM, Sapin V, Beauvieux MC, Levy P

Ann Biol Clin (Paris). 2021 Jun 24;:

Sirolimus Pharmacokinetics Variability Points to the Relevance of Therapeutic Drug Monitoring in Pediatric Oncology.

Sabo AN, Jannier S, Becker G, Lessinger JM, Entz-Werlé N, Kemmel V

Pharmaceutics. 2021 Mar 30;13(4):

Empagliflozin improved systolic blood pressure, endothelial dysfunction and heart remodeling in the metabolic syndrome ZSF1 rat.

Park SH, Farooq MA, Gaertner S, Bruckert C, Qureshi AW, Lee HH, Benrahla D, Pollet B, Stephan D, Ohlmann P, Lessinger JM, Mayoux E, Auger C, Morel O, Schini-Kerth VB

Cardiovasc Diabetol. 2020 Feb 18;19(1):19

Interleukin-6 chemiluminescent immunoassay on Lumipulse G600 II: analytical evaluation and comparison with three other laboratory analyzers.

Glady L, Lavaux T, Charchour R, Lacorte JM, Lessinger JM

Clin. Chem. Lab. Med.. 2020 Jan 11;:

Prognosis of patients with severe hyponatraemia is related not only to hyponatraemia but also to comorbidities and to medical management: results of an observational retrospective study.

Krummel T, Prinz E, Metten MA, Borni-Duval C, Bazin-Kara D, Charlin E, Lessinger JM, Hannedouche T

BMC Nephrol. 2016 Oct;17(1):159

In vivo evaluation of a reverse water-in-fluorocarbon emulsion stabilized with a semifluorinated amphiphile as a drug delivery system through the pulmonary route.

Courrier HM, Pons F, Lessinger JM, Frossard N, Krafft MP, Vandamme TF

Int J Pharm. 2004 Sep;282(1-2):131-40

Fiche personne Projets Publications

Retrouvez aussi

Personnes

Equipes

Plateformes

Unités de recherche, établissements

Projets de recherche

Publications scientifiques

Pr LESSINGER Jean-Marc

Fiche personne

Coordonnées

Territoire

Statut

Affiliation

Équipes/plateformes

Recherche

Projets

Détection prospective des biomarqueurs émergents dans le cancer du poumon, le cancer colo-recta et le mélanome

Publications

Potential of dapagliflozin to prevent vascular remodeling in the rat carotid artery following balloon injury.

COVID-19 promotes endothelial dysfunction and thrombogenicity: Role of pro-inflammatory cytokines/SGLT2 pro-oxidant pathway.

COVID-19 exposure in SARS-CoV-2-seropositive hospital staff members during the first pandemic wave at Strasbourg University Hospital, France.

High SARS-CoV-2 seroconversion rate among geriatric staff from Strasbourg University Hospitals.

Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection.

[Myocardial injury in coronavirus disease 19 (Covid-19): main pathophysiological mechanisms and clinical utility of cardiac biomarkers].

Sirolimus Pharmacokinetics Variability Points to the Relevance of Therapeutic Drug Monitoring in Pediatric Oncology.

Empagliflozin improved systolic blood pressure, endothelial dysfunction and heart remodeling in the metabolic syndrome ZSF1 rat.

Interleukin-6 chemiluminescent immunoassay on Lumipulse G600 II: analytical evaluation and comparison with three other laboratory analyzers.

Optimizing Hydroxyurea Treatment for Sickle Cell Disease Patients: The Pharmacokinetic Approach.

A novel machine learning-derived decision tree including uPA/PAI-1 for breast cancer care.

Commutability Assessment of Candidate Reference Materials for Pancreatic α-Amylase.

A single-nucleotide polymorphism of ABCB1 (MDR1) is correlated with poor response to Imatinib chronic myeloid leukemia.

Rifampicin reverses nicardipine effect inducing uncontrolled essential hypertension.

Prognosis of patients with severe hyponatraemia is related not only to hyponatraemia but also to comorbidities and to medical management: results of an observational retrospective study.

In vivo evaluation of a reverse water-in-fluorocarbon emulsion stabilized with a semifluorinated amphiphile as a drug delivery system through the pulmonary route.

Retrouvez aussi